Abstract
Diabetic kidney disease is one of the main causes of end-stage renal disease. During the past decades, proteomic analysis based on mass spectrometry has been playing a momentous role in revealing potential biomarkers of diabetic kidney disease.Assays using New combination of multiple biomarkers can help identify high risk patients and give positive guidance of therapies.(Chin J Lab Med, 2016, 39: 885-887) Key words: Diabetic nephropathies; Proteomics; Biological markers; Mass spectrometry
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
